The management and outcome of hospitalized and ambulatory Israeli heart failure patients compared to European heart failure patients: Results from the ESC heart failure long-term registry

Avraham Shotan, Barak Zafrir, Tuvia Ben Gal, Alicia Vazan, Israel Gotsman, Offer Amir

Research output: Contribution to journalArticlepeer-review

6 Scopus citations

Abstract

Background: The treatment of patients hospitalized with heart failure (HHF) and ambulatory chronic heart failure (CHF) differs in various countries. Objectives: To evaluate the management and outcomes of patients with HFF and CHF in Israel compared to those in other European countries who were included in the ESC-HF LongTerm Registry. Methods: From May 2011 to April 2013, heart failure patients – 467 Israelis and 11,973 from other countries – were evaluated. The Israeli patients comprised 178 with HHF and 289 with CHF. One year outcomes, including all-cause and cardiovascular mortality as well as HHF, were evaluated. Results: The HHF Israeli patients were older than their CHF Israeli counterparts, had more co-morbidities, included more women, and were treated less frequently with medications suggested by European guidelines. The Israeli HHF patients had similar all-cause 1 year mortality rates compared to HHF patients from other participating countries, but their cardiovascular (CV) mortality was lower, while a significantly higher rate of all-cause and HHF was noted. The Israeli CHF patients were older, suffered from more co-morbidities and had prior cardio-electronic implantable devices. In addition, they had higher mortality rates, especially non-CV, and were more frequently hospitalized, compared to CHF patients from other countries. Conclusions: The Israeli patients with heart failure differed in their baseline characteristics and the therapeutic approach. Despite high usage of treatments recommended by official guidelines, especially among CHF patients, mortality, particularly in HHF patients, remained high.

Original languageEnglish
Pages (from-to)225-230
Number of pages6
JournalIsrael Medical Association Journal
Volume19
Issue number4
StatePublished - Apr 2017

Bibliographical note

Publisher Copyright:
© 2017, Israel Medical Association. All rights reserved.

Funding

The survey in Israel was funded by the ESC, as is the case for each participating national cardiology society. Additional grant support was provided by Pfizer Israel and Astra Zenica Israel.

FundersFunder number
Pfizer Israel and Astra Zenica Israel
European Society of Contraception and Reproductive Health

    Keywords

    • Angiotensin-converting enzyme (ACE) inhibitors
    • Beta-blockers
    • Heart failure (HF)
    • Mortality
    • Rehospitalization

    Fingerprint

    Dive into the research topics of 'The management and outcome of hospitalized and ambulatory Israeli heart failure patients compared to European heart failure patients: Results from the ESC heart failure long-term registry'. Together they form a unique fingerprint.

    Cite this